NCT07620535Not yet recruiting
Decision Counseling and Follow-up for Shield+ Patients
Decision Counseling and Follow-up (DCaF) for Shield+ Patients
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 350 (estimated)
- First submitted
- 27 May 2026
- Start date
- Jun 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Guardant Health, Inc.
- Diseases
- Colorectal cancer
- NCT number
- NCT07620535
What you commit to
- Study type: Observational
- Planned participants: 350
- From Jun 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participant is already enrolled in another Guardant Health, Inc. clinical study or has received a positive MCD result for a cancer type other than CRC.
Who the study is looking for
- Participant is 45-75 years old at the time of ShieldTM test order.
- Participant has a valid Shield(+) test result.
- Participant is willing and able to complete the informed consent process
- Participant is able to complete the informed consent process and decision counseling session in English
Age in the registry: 45 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jefferson Center Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.